drugset / Trial / NCT07794592
A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study is to compare how much and how quickly olomorasib gets into the bloodstream when it is taken in 2 different ways, and to check for any side effects. For each participant, the study will last about 6 weeks and will include 1 stay in the Clinical Research Unit (CRU) which consists of 7 nights.
Timeline
- Start
- 2026-08-28
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olomorasib | Small molecule | — | Oral |
Indications
No indication recorded.